Wisynco Group Limited (JMSE:WISYNCO)

Inozyme Pharma Ratios and Metrics

Market cap in millions JMD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	75,253	79,493	67,575	74,853	58,125	71,138
Market Cap Growth	6.42%	17.64%	-9.72%	28.78%	-18.29%	-0.68%
Enterprise Value	71,921	77,260	61,838	67,390	53,361	68,719
Last Close Price	20.00	20.46	17.00	18.42	13.99	16.93
PE Ratio	16.03	15.32	13.73	18.47	18.92	25.38
PS Ratio	1.33	1.47	1.39	1.92	1.83	2.21
PB Ratio	2.74	3.21	3.20	4.20	3.86	5.48
P/TBV Ratio	2.74	3.21	3.20	4.20	3.87	5.50
P/FCF Ratio	41.61	-	33.97	27.89	14.28	32.33
P/OCF Ratio	9.83	9.92	15.50	24.08	12.46	19.37
EV/Sales Ratio	1.27	1.42	1.27	1.73	1.68	2.14
EV/EBITDA Ratio	10.37	11.23	8.74	11.78	11.36	16.55
EV/EBIT Ratio	13.47	13.12	10.09	13.85	14.34	22.50
EV/FCF Ratio	39.76	-	31.09	25.11	13.11	31.23
Debt / Equity Ratio	0.11	0.13	0.19	0.09	0.14	0.18
Debt / EBITDA Ratio	0.44	0.47	0.57	0.27	0.45	0.56
Debt / FCF Ratio	1.69	-	2.06	0.59	0.53	1.08
Asset Turnover	1.60	1.57	1.67	1.62	1.53	1.74
Inventory Turnover	6.54	5.69	5.51	5.73	5.99	6.45
Quick Ratio	1.39	1.06	1.81	1.61	1.80	1.73
Current Ratio	2.12	1.77	2.77	2.44	2.42	2.47
Return on Equity (ROE)	18.15%	22.61%	25.27%	24.65%	21.92%	22.13%
Return on Assets (ROA)	9.41%	10.64%	13.15%	12.60%	11.17%	10.30%
Return on Capital (ROIC)	11.44%	13.81%	17.17%	16.61%	14.29%	13.11%
Return on Capital Employed (ROCE)	17.90%	21.50%	25.40%	26.10%	22.60%	20.70%
Earnings Yield	6.24%	6.53%	7.29%	5.42%	5.29%	3.94%
FCF Yield	2.40%	-1.04%	2.94%	3.59%	7.00%	3.09%
Dividend Yield	2.22%	2.25%	2.65%	2.17%	2.15%	1.06%
Payout Ratio	36.83%	33.30%	32.03%	37.01%	23.19%	25.42%
Buyback Yield / Dilution	-0.57%	-0.32%	-0.03%	-0.14%	-0.06%	-0.03%
Total Shareholder Return	1.64%	1.93%	2.61%	2.03%	2.09%	1.03%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.